For: | Jayasekera D, Hartmann P. Noninvasive biomarkers in pediatric nonalcoholic fatty liver disease. World J Hepatol 2023; 15(5): 609-640 [PMID: 37305367 DOI: 10.4254/wjh.v15.i5.609] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v15/i5/609.htm |
Number | Citing Articles |
1 |
Maria Oana Săsăran, Carmen Muntean, Ancuța Lupu, Vasile Valeriu Lupu. Neutrophils: tissue and circulating signatures of pediatric non-alcoholic fatty liver disease. Frontiers in Cell and Developmental Biology 2024; 11 doi: 10.3389/fcell.2023.1336033
|
2 |
Sunitha Vimalesvaran, Pietro Vajro, Anil Dhawan. Pediatric metabolic (dysfunction)-associated fatty liver disease: current insights and future perspectives. Hepatology International 2024; 18(S2): 873 doi: 10.1007/s12072-024-10691-5
|
3 |
Greta Viebahn, Phillipp Hartmann, Sonja Lang, Münevver Demir, Xinlian Zhang, Derrick E. Fouts, Peter Stärkel, Bernd Schnabl. Fungal signature differentiates alcohol-associated liver disease from nonalcoholic fatty liver disease. Gut Microbes 2024; 16(1) doi: 10.1080/19490976.2024.2307586
|
4 |
Claudia Mandato, Pietro Vajro. Serum alanine aminotransferase: Are we still far from a one‐size‐fits‐all pediatric reference cutoff strategy?. Journal of Pediatric Gastroenterology and Nutrition 2024; 78(3): 453 doi: 10.1002/jpn3.12037
|